BASi (BASI) Names Dawn M. Joseph Director Of Business Development

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Bioanalytical Systems, Inc. ("BASi") (NASDAQ:BASI) today announced the appointment of Dawn M. Joseph as Director of Business Development reporting to BASi Vice President of Business Development, Connie Dougherty. Ms. Dougherty said, "Dawn Joseph joins BASi with 11 years of experience in the pharmaceutical services market as a business development manager, with a track record of building sales and implementing winning initiatives for the clients.

Suggested Articles

Karen DeSalvo's appointment is the latest in a string of hires that deepen the tech giant’s investment in and focus on healthcare.

Spring Bank’s hepatitis B drug, given in tandem with Gilead’s Vemlidy, tamped down on chronic disease in 23% of patients in a phase 2 study.

Gilead names Dickinson to CFO role; MedImmune CSO Herbst nabs CSO job at Pyxis; Checkmate picks up Wooldridge for CMO.